Department of Orthopaedic Surgery, University of Southern California, Los Angeles, California, U.S.A..
Department of Orthopaedic Surgery, University of Southern California, Los Angeles, California, U.S.A.
Arthroscopy. 2019 Mar;35(3):717-724. doi: 10.1016/j.arthro.2018.10.116. Epub 2019 Feb 4.
To determine whether shoulder injections prior to rotator cuff repair (RCR) are associated with deleterious surgical outcomes.
Two large national insurance databases were used to identify a total of 22,156 patients who received ipsilateral shoulder injections prior to RCR. They were age, sex, obesity, smoking status, and comorbidity matched to a control group of patients who underwent RCR without prior injections. The 2 groups were compared regarding RCR revision rates.
Patients who received injections prior to RCR were more likely to undergo RCR revision than matched controls (odds ratio [OR], 1.52; 95% confidence interval [CI], 1.38-1.68; P < .0001). Patients who received injections closer to the time of index RCR were more likely to undergo revision (P < .0001). Patients who received a single injection prior to RCR had a higher likelihood of revision (OR, 1.25; 95% CI, 1.10-1.43; P = .001). Patients who received 2 or more injections prior to RCR had a greater than 2-fold odds of revision (combined OR, 2.12; 95% CI, 1.82-2.47; P < .0001) versus the control group.
This study strongly suggests a correlation between preoperative shoulder injections and revision RCR. There is also a frequency dependence and time dependence to this finding, with more frequent injections and with administration of injections closer to the time of surgery both independently associated with higher revision RCR rates. Presently, on the basis of this retrospective database study, orthopaedic surgeons should exercise due caution regarding shoulder injections in patients whom they are considering to be surgical candidates for RCR.
Level III, therapeutic study.
确定肩袖修补术 (RCR) 前进行肩部注射是否与不良手术结果相关。
使用两个大型国家保险数据库,共确定了 22156 例在 RCR 前接受同侧肩部注射的患者。他们在年龄、性别、肥胖、吸烟状况和合并症方面与未接受注射而接受 RCR 的对照组患者相匹配。比较两组 RCR 翻修率。
接受 RCR 前注射的患者比匹配的对照组更有可能接受 RCR 翻修(优势比 [OR],1.52;95%置信区间 [CI],1.38-1.68;P<.0001)。接受注射更接近索引 RCR 时间的患者更有可能接受翻修(P<.0001)。接受 RCR 前单次注射的患者翻修的可能性更高(OR,1.25;95%CI,1.10-1.43;P=.001)。接受 RCR 前 2 次或更多次注射的患者翻修的可能性是对照组的 2 倍以上(联合 OR,2.12;95%CI,1.82-2.47;P<.0001)。
本研究强烈表明术前肩部注射与 RCR 翻修之间存在相关性。这种发现也存在频率依赖性和时间依赖性,更频繁的注射以及更接近手术时间的注射均与更高的 RCR 翻修率独立相关。目前,基于这项回顾性数据库研究,对于那些正在考虑手术治疗肩袖修补术的患者,骨科医生应谨慎对待肩部注射。
III 级,治疗研究。